Chinese brain-computer interface companies are poised for rapid growth as the government supports the development of global leaders in the sector by 2030. With backing from policies outlined by seven ministries, China aims to achieve significant technological advancements by 2027, establishing a robust industrial framework. While specific companies for support remain unnamed, the ambition to create leading players has stirred investor interest, with shares in Nanjing Panda Electronics and MicroPort NeuroScientific seeing notable increases. This initiative highlights China’s commitment to advancing BCI technology, with clinical trials and specialized hospital wards already underway.
Can China’s BCI firms compete with Elon Musk’s Neuralink?
